CLINICAL_TRIALS
trial_result
· 2014-05-12
Clinical Trial Update: A 28-week Safety Study of Flibanserin in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder [Phase 3]
Summary
Phase 3 safety study of flibanserin in pre- and postmenopausal women with hypoactive sexual desire disorder was terminated; results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sprout Pharmaceuticals, Inc | Conditions: Sexual Dysfunctions, Psychological | Phase 3 | Status: TERMINATED | Results posted: 2014-05-12